Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredients Fluticasone and Azelastine (R01ad28) as Part of a So-Called Open House Model.

Medicines with the Active Ingredient Combination Oxycodone and Naloxone (Atc: N02aa55)

Testing System "Planning Services for Cable Systems in the High and Extra-High Voltage Network of the Austrian Power Grid

Das Information

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Pancreatin, Lipase-Containing Multienzymes (A09aa02) as Part of a So-Called Open-Hospital...

Sub-Contract 2: Pcr Instrument, Real Time Pcr

Equipment for Hybrid Training

25207 Sap Licenses and Their Support Services

Brain Initiative: Next-generation Devices for Recording and Modulation in the Human Central Nervous System (ug3/uh3 Clinical Trial Optional)

Category 8 - Accessory